drugset / Trial / NCT00144482
A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the effectiveness and safety in randomized, double-blind, parallel-group study in anemic cancer patients undergoing chemotherapy
Timeline
- Start
- 2003-12
- Primary completion
- 2005-03
- Completion
- 2005-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | 36000 iu | Subcutaneous |